Cervarix Adjuvant Could Provide Longer Cancer Immune Response, GSK Says
This article was originally published in The Pink Sheet Daily
Executive Summary
GSK's AS04 adjuvant demonstrates increased immune memory compared to aluminum adjuvants, such as the one used in Merck's Gardasil HPV vaccine.